Clinical Trials, Studies, Registries, Data

The ongoing HIVEC HEAT trial aims to generate clinical data to evidence the efficacy of hyperthermic intravesical 80mg mitomycin C chemotherapy for patients with BCG-unresponsive, high risk NMIBC